These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23827598)

  • 21. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts.
    Steigerwald K; Merl S; Kastrati A; Wieczorek A; Vorpahl M; Mannhold R; Vogeser M; Hausleiter J; Joner M; Schömig A; Wessely R
    Biomaterials; 2009 Feb; 30(4):632-7. PubMed ID: 18990438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An investigation of adhesion in drug-eluting stent layers.
    Wolf KV; Zong Z; Meng J; Orana A; Rahbar N; Balss KM; Papandreou G; Maryanoff CA; Soboyejo W
    J Biomed Mater Res A; 2008 Oct; 87(1):272-81. PubMed ID: 18306306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
    Grube E; Buellesfeld L
    Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R; Pakala R
    EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional time-of-flight secondary ion mass spectrometry imaging of a pharmaceutical in a coronary stent coating as a function of elution time.
    Fisher GL; Belu AM; Mahoney CM; Wormuth K; Sanada N
    Anal Chem; 2009 Dec; 81(24):9930-40. PubMed ID: 19919043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three-dimensional compositional analysis of drug eluting stent coatings using cluster secondary ion mass spectrometry.
    Mahoney CM; Fahey AJ; Belu AM
    Anal Chem; 2008 Feb; 80(3):624-32. PubMed ID: 18179243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
    Jabara R; Chronos N; Robinson K
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly-(L-lactic acid) and citric acid-crosslinked gelatin composite matrices as a drug-eluting stent coating material with endothelialization, antithrombogenic, and drug release properties.
    Inoue M; Sasaki M; Katada Y; Fujiu K; Manabe I; Nagai R; Taguchi T
    J Biomed Mater Res A; 2013 Jul; 101(7):2049-57. PubMed ID: 23280946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro blood and vascular compatibility of sirolimus-eluting organic/inorganic hybrid stent coatings.
    Jang TS; Cheon KH; Ahn JH; Song EH; Kim HE; Jung HD
    Colloids Surf B Biointerfaces; 2019 Jul; 179():405-413. PubMed ID: 30999119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus.
    Chen MC; Liang HF; Chiu YL; Chang Y; Wei HJ; Sung HW
    J Control Release; 2005 Nov; 108(1):178-89. PubMed ID: 16162366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mathematical model for predicting drug release from a biodurable drug-eluting stent coating.
    Hossainy S; Prabhu S
    J Biomed Mater Res A; 2008 Nov; 87(2):487-93. PubMed ID: 18186043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirolimus-eluting dextran and polyglutamic acid hybrid coatings on AZ31 for stent applications.
    Ma J; Zhao N; Zhu D
    J Biomater Appl; 2015 Nov; 30(5):579-88. PubMed ID: 26202889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter.
    Lemos PA; Farooq V; Takimura CK; Gutierrez PS; Virmani R; Kolodgie F; Christians U; Kharlamov A; Doshi M; Sojitra P; van Beusekom HM; Serruys PW
    EuroIntervention; 2013 May; 9(1):148-56. PubMed ID: 23685303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
    Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK
    J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
    Ray GM; Nawarskas JJ; Frishman WH
    Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-restenosis study on a new drug eluting stent].
    Zhao A; Zhang H; Huang N; Zhang B; Yang K; Li Z; Zhao H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):856-9, 878. PubMed ID: 18788296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.